Welcome to our dedicated page for Strata Skin Sciences news (Ticker: $SSKN), a resource for investors and traders seeking the latest updates and insights on Strata Skin Sciences stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Strata Skin Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Strata Skin Sciences's position in the market.
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced the presentation of a poster titled 'Pulsed Broadband Light with Vacuum Suction (Photopneumatic Therapy) and Needle Insert to Treat Acne' at the Maui Derm 2024 Meeting. The poster highlights the safety and efficacy of one treatment session using STRATA’s TheraClear®X technology for cystic and papular acne reduction. Majority of lesions demonstrated ≥50% clearing by 1-2 weeks, exceeding the criteria of ≥30% reduction in lesion size at two follow-up visits. The most frequently reported event was mild hyperpigmentation, while erythema, edema, and flaking were observed in ≤10% of lesions. The clinical evaluation continues to highlight the efficacy and safety of the TheraClear®X system for treating acne.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
-
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has been granted a 180-day extension by Nasdaq to regain compliance with the minimum bid price rule. The company received a notification letter from Nasdaq regarding its noncompliance with the minimum closing bid price requirement and has until June 24, 2024, to meet the $1.00 per share bid price for 10 consecutive business days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
-
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announces an expansion of its direct distribution agreement with Kosmo Meditech, now assigned to Kosmo's corporate parent, Cutech, Inc., effective January 1, 2024. The amendment extends the term through December 31, 2026, with defined annual and quarterly performance-based purchase requirements, making STRATA the sole provider of gas and consumables in Korea.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) promotes Shmuel Gov to Chief Operating Officer and hires Dr. Amandeep Kaur as Vice President of Marketing and Business Growth. Gov brings 30 years of industry experience and Kaur rejoins the company with a background in business development, marketing, and technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
-
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) to Participate in Benchmark 12th Annual Discovery One-on-One Investor Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12%
Tags
-
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) Announces Q3 2023 Financial Results and Management Change
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.62%
Tags
Rhea-AI Summary
STRATA Skin Sciences, Inc. plans to release its third quarter 2023 financial results on November 14, 2023. A conference call will be held at 4:30 PM ET on the same day to review the financial results and provide a corporate update. The event will be archived on the company's website for future reference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
-
Rhea-AI Summary
STRATA Skin Sciences, Inc. announced that Dr. Dolev Rafaeli has been granted an equity-based award as an inducement for joining the company as its Vice-Chairman, CEO, and President. The award consists of a stock option to purchase 1,754,569 shares of the company's common stock, with a strike price of $0.53 per share. The options will vest over a three-year period, with the first batch of 145,465 options vesting on January 31, 2024, and subsequent batches vesting every three months thereafter, subject to Dr. Rafaeli's continued employment and the terms of the award agreement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Bob Moccia steps down as CEO and member of the Board of STRATA Skin Sciences, Inc. Dr. Dolev Rafaeli is named the new Vice-Chairman, President, and CEO. Dr. Rafaeli brings over 30 years of experience in various industries, including healthcare and medical devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.66%
Tags
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) will be participating in two medical conferences in October.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
Strata Skin Sciences, Inc.
Nasdaq:SSKN
SSKN Rankings
SSKN Stock Data
13.15M
11.94M
4.26%
67.01%
0.61%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
HORSHAM
About SSKN
formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.